单核苷酸多态性（SNP）市场展望：机遇、技术与产品 - Suppr

Suppr

超能文献

SNP market view: opportunities, technologies, and products.

作者信息

Wypgant Matthew

机构信息

Matthew Wygant Biotech Writing, Los Gatos, CA 95032, USA.

出版信息

Biotechniques. 2002 Jun;Suppl:78-80, 82, 84 passim.

PMID:12083402

Abstract

摘要

相似文献

SNP market view: opportunities, technologies, and products.

Biotechniques. 2002 Jun;Suppl:78-80, 82, 84 passim.

Genomic sciences and the medicine of tomorrow.

Nat Biotechnol. 1996 Nov;14(11):1516-8. doi: 10.1038/nbt1196-1516.

R&D deals boom in 2004.

Nat Biotechnol. 2005 Sep;23(9):1036. doi: 10.1038/nbt0905-1036.

BeadArray-based solutions for enabling the promise of pharmacogenomics.

Biotechniques. 2005 Oct;39(4):583-8.

Biotech's billion dollar breakthrough.

Fortune. 2003 May 26;147(10):96-8, 100, 103.

Biotech drugs come of age; policymakers take notice.

Health Aff (Millwood). 2006 Sep-Oct;25(5):1202-3. doi: 10.1377/hlthaff.25.5.1202.

Applying technologies towards safe and effective medicines.

Biotechniques. 2005 Oct;39(4):563-4.

The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.

Stud Hist Philos Biol Biomed Sci. 2006 Sep;37(3):583-601. doi: 10.1016/j.shpsc.2006.06.002. Epub 2006 Aug 23.

Screening for drug discovery: the leading question.

Nature. 2002 Jul 25;418(6896):453-9. doi: 10.1038/418453a.

Pharmacogenetics initiative galvanizes public and private sectors.

Nature. 2001 Mar 15;410(6826):393-4. doi: 10.1038/35066732.

引用本文的文献

Gene expression profiling: from microarrays to medicine.

J Clin Immunol. 2004 May;24(3):213-24. doi: 10.1023/B:JOCI.0000025443.44833.1d.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

SNP market view: opportunities, technologies, and products.

Biotechniques. 2002 Jun;Suppl:78-80, 82, 84 passim.

Genomic sciences and the medicine of tomorrow.

Nat Biotechnol. 1996 Nov;14(11):1516-8. doi: 10.1038/nbt1196-1516.

R&D deals boom in 2004.

Nat Biotechnol. 2005 Sep;23(9):1036. doi: 10.1038/nbt0905-1036.

BeadArray-based solutions for enabling the promise of pharmacogenomics.

Biotechniques. 2005 Oct;39(4):583-8.

Biotech's billion dollar breakthrough.

Fortune. 2003 May 26;147(10):96-8, 100, 103.

Biotech drugs come of age; policymakers take notice.

Health Aff (Millwood). 2006 Sep-Oct;25(5):1202-3. doi: 10.1377/hlthaff.25.5.1202.

Applying technologies towards safe and effective medicines.

Biotechniques. 2005 Oct;39(4):563-4.

The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.

Stud Hist Philos Biol Biomed Sci. 2006 Sep;37(3):583-601. doi: 10.1016/j.shpsc.2006.06.002. Epub 2006 Aug 23.

Screening for drug discovery: the leading question.

Nature. 2002 Jul 25;418(6896):453-9. doi: 10.1038/418453a.

Pharmacogenetics initiative galvanizes public and private sectors.

Nature. 2001 Mar 15;410(6826):393-4. doi: 10.1038/35066732.

引用本文的文献

Gene expression profiling: from microarrays to medicine.

J Clin Immunol. 2004 May;24(3):213-24. doi: 10.1023/B:JOCI.0000025443.44833.1d.